Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 26, 2015 11:02 PM ET

Healthcare Providers and Services

Company Overview of Pathology, Inc.

Company Overview

Pathology, Inc. operates women's health laboratories that engage in the specimen preparation and testing of patient samples. The company offers reproductive FDA donor, anatomic, molecular, digital pathology, cytology, histology, immunohistochemistry, hematopathology, and flow cytometry testing services; breast, head and neck, endocrine, gastrointestinal, genitourinary, hepatic, and pulmonary pathology, as well as cytopathology and dermatopathology services; and biopsy, clinical testing, consultation, gastroenterology, microbiology testing, microbial analysis, and urology testing services, as well as E6/E7 cell transformation alert assays. It provides its services for clinicians, pathologists...

19951 Mariner Avenue

Suite 150

Torrance, CA 90503-1738

United States

Founded in 1979





Key Executives for Pathology, Inc.

Chief Executive Officer and President
Age: 59
Co-Founder, Chairman of the Board and Chief Medical Officer
Chief Financial Officer
Age: 65
Senior Vice President of Operations
Senior Vice President of Revenue Services
Compensation as of Fiscal Year 2014.

Pathology, Inc. Key Developments

Pathology, Inc. and CombiMatrix Corporation Expand Partnership in Prenatal Testing Market

CombiMatrix Corporation announced that it has been selected by Pathology, Inc. to be its exclusive provider of chromosomal microarray tests for the Products of Conception (POC) testing market throughout the United States. POC testing, also referred to as miscarriage testing, is a subset of the overall prenatal testing market. The announcement is an expansion of the previous strategic partnership between the two companies announced in November 2012 that gave Pathology, Inc. the right to market and distribute microarray tests on behalf of CombiMatrix in the states of California and Nevada, as well as the St. Louis and Chicago metropolitan areas.

Similar Private Companies By Industry

Company Name Region
Lake Cumberland Regional Hospital, LLC United States
New Trident Holdcorp Inc. United States
Brandon Wilde Life Care Community United States
UROHSD, LLC United States
Livingston Community Health Services, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pathology, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at